- Home
- MLYS vs SEAT Comparison
MLYS vs SEAT Comparison
Compare MLYS & SEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLYS
- SEAT
- Stock Information
- Founded
- MLYS 2019
- SEAT 2001
- Country
- MLYS United States
- SEAT United States
- Employees
- MLYS N/A
- SEAT N/A
- Industry
- MLYS Biotechnology: Pharmaceutical Preparations
- SEAT Industrial Machinery/Components
- Sector
- MLYS Health Care
- SEAT Industrials
- Exchange
- MLYS Nasdaq
- SEAT Nasdaq
- Market Cap
- MLYS 526.1M
- SEAT 622.1M
- IPO Year
- MLYS 2023
- SEAT N/A
- Fundamental
- Price
- MLYS $10.21
- SEAT $4.48
- Analyst Decision
- MLYS Strong Buy
- SEAT Strong Buy
- Analyst Count
- MLYS 2
- SEAT 10
- Target Price
- MLYS $30.00
- SEAT $6.73
- AVG Volume (30 Days)
- MLYS 263.5K
- SEAT 1.1M
- Earning Date
- MLYS 03-20-2025
- SEAT 03-04-2025
- Dividend Yield
- MLYS N/A
- SEAT N/A
- EPS Growth
- MLYS N/A
- SEAT N/A
- EPS
- MLYS N/A
- SEAT N/A
- Revenue
- MLYS N/A
- SEAT $774,076,000.00
- Revenue This Year
- MLYS N/A
- SEAT $10.17
- Revenue Next Year
- MLYS N/A
- SEAT $4.02
- P/E Ratio
- MLYS N/A
- SEAT N/A
- Revenue Growth
- MLYS N/A
- SEAT 13.91
- 52 Week Low
- MLYS $8.58
- SEAT $3.24
- 52 Week High
- MLYS $16.91
- SEAT $6.41
- Technical
- Relative Strength Index (RSI)
- MLYS 44.53
- SEAT 49.56
- Support Level
- MLYS $9.57
- SEAT $4.13
- Resistance Level
- MLYS $10.79
- SEAT $4.78
- Average True Range (ATR)
- MLYS 0.64
- SEAT 0.26
- MACD
- MLYS 0.11
- SEAT -0.08
- Stochastic Oscillator
- MLYS 63.98
- SEAT 26.67
About MLYS Mineralys Therapeutics Inc.
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking three or more antihypertensive medications typically including a diuretic.
About SEAT Vivid Seats Inc.
Vivid Seats Inc is an online ticket marketplace for connecting fans to live events and artists. It is the official ticketing partner of brands in the entertainment industry providing tickets for sports, concerts, theatres, and comedy events in the United States, Canada and Japan. It operates in two segments namely marketplace and resale.